Looking for leads, investment insights, or competitive intelligence?
News about Roche Group
Must-read business news, delivered every morning.
Shionogi and Genentech's Xofluza may treat certain people's flu symptoms faster.
From genetic testing giants to copycat drug manufacturers, here are the global companies set to make a mark on medicine.
But Shionogi's Xofluza likely won't be available in the U.S. till at least 2019.
Flatiron is connected with hundreds of cancer treatment centers—and its data collection could spur new drugs.